Ajanta Pharma Limited has announced its schedule for analyst and institutional investor meetings to be held in August 2026. The company will participate in the Nuvama India Conference 2026 from August 11th to 13th and the Motilal Annual Global Conference on August 18th. These meetings are intended to facilitate discussions based on previously published information.
Upcoming Investor Engagement
Ajanta Pharma Limited is set to engage with analysts and institutional investors through scheduled meetings in August 2026. This initiative aligns with the company’s commitment to transparent communication and providing stakeholders with direct access to management.
Key Conferences Scheduled
The company will be participating in two significant industry events:
- The Nuvama India Conference 2026, which includes a Singapore & Hong Kong edition, is scheduled from August 11th to August 13th, 2026. This will be a one-on-one meeting format.
- The Motilal Annual Global Conference will take place on August 18th, 2026.
Meeting Details and Information Disclosure
The meetings are scheduled to take place in Singapore & Hongkong for the Nuvama conference and at the Grand Hyatt, Santacruz for the Motilal conference. Ajanta Pharma confirms that all discussions during these investor interactions will be strictly based on information that has already been published and made available to the public. The company also notes that the schedule is subject to change due to unforeseen circumstances.
Source: BSE
